# Bioequivalence Assessment Between Two Imeglimin Hydrochloride Film Coated Tablet Formulations

> **NCT07127094** · PHASE1 · COMPLETED · sponsor: **Aya Mohammed Abdel Magid Abdel Hamid** · enrollment: 29 (actual)

## Conditions studied

- Bioequivalence Study in Healthy Subjects

## Interventions

- **DRUG:** Test Product (Glimcoza)
- **DRUG:** Reference (R) Twymeeg®

## Key facts

- **NCT ID:** NCT07127094
- **Lead sponsor:** Aya Mohammed Abdel Magid Abdel Hamid
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-09
- **Primary completion:** 2025-06-18
- **Final completion:** 2025-06-18
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2025-08-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07127094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07127094, "Bioequivalence Assessment Between Two Imeglimin Hydrochloride Film Coated Tablet Formulations". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07127094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*